The degenerative environment of chronic tendinopathy lacks the active cellular repair response present in acute injuries, and BPC-157's ability to initiate fibroblast migration and growth factor receptor upregulation addresses the biological deficit underlying the chronic state
Wolff law states that bone adapts to the loads placed upon it, and remodeling follows this principle precisely
For patients dealing with multi-site issues (shoulder plus lower back, for example), an older injury that has not fully resolved, or systemic inflammation affecting more than one area, BPC-157 is often combined with TB-500 in our Wolverine Stack protocol
[62] [63] The mechanism of action is straightforward: the hydroxycobalamin hydroxide ligand is displaced by the toxic cyanide ion, and the resulting non-toxic cyanocobalamin is excreted in urine
Oral or sublingual BPC-157 is preferred for gut health because the peptide acts directly on the GI mucosa when delivered through the digestive tract